Asahi Kasei Pharma Ventures
Overview
Asahi Kasei Pharma Ventures is the corporate venture capital arm of Asahi Kasei Pharma, investing globally in private, early-stage biopharmaceutical companies with a focus on innovative therapeutics and platforms.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mediar Therapeutics | Jan 2026 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Asahi Kasei Pharma Ventures based?
Asahi Kasei Pharma Ventures is headquartered in Chelmsford, Massachusetts, United States.
When was Asahi Kasei Pharma Ventures founded?
Asahi Kasei Pharma Ventures was founded in 2018.
How many portfolio companies does Asahi Kasei Pharma Ventures have?
Asahi Kasei Pharma Ventures has 1 portfolio company in Caplight's dataset.
What are some companies in Asahi Kasei Pharma Ventures's portfolio?
Portfolio companies visible on Caplight include Mediar Therapeutics.
What was Asahi Kasei Pharma Ventures's most recent investment shown here?
Asahi Kasei Pharma Ventures's most recent investment in this portfolio sample was in Mediar Therapeutics in 2026.
What sectors does Asahi Kasei Pharma Ventures focus on?
Asahi Kasei Pharma Ventures focuses on Healthcare & Life Sciences.
What company stages does Asahi Kasei Pharma Ventures focus on?
Asahi Kasei Pharma Ventures typically invests at the Mid stage.